SonoSite (NSDQ:SONO) CFO Marcus Smith stands to pull down more than $3 million now that he’s retired from the Bothell, Wash.-based ultrasound device maker.
The company said Smith’s resignation, which went into effect yesterday, was to pursue other opportunities.
The former Philips Medical Systems exec will end up with more than $3 million in the bank after he receives all of his separation benefits, according to a company filing with the SEC.
Sign up to get our free newsletters delivered straight to your inbox
Smith will end up with 3 lump sum payments of $790,000, equivalent to 2 years worth of salary and bonuses, and $1.3 million and $1.7 million for restricted stock units and options, respectively.
SonoSite hired Smith in 2007 as the vice president of corporate strategy & growth planning and promoted him to a senior VP and CFO in August 2010.
SonoSite said it’s replacing Smith with Anil Amlani, head of its VisualSonics subsidiary.
A seasoned corporate operator, Amlani has logged 11 years financial chief at various companies, according to SonoSite president & CEO Kevin Goodwin, including a 5-year stint as president & CEO of VisualSonics before SonoSite’s summer 2010 buyout of the ultrasound device maker.
SonoSite, which paid $71 million for VisualSonics, found itself on the other end of the equation with nearly $1 billion offer from Fujifilm (TSE:4901) last month.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Novocure names new CFO
Wilco Groenhuysen, former CFO of Cephalon Inc. and Philips Electronics takes the financial reigns at oncology treatment device maker Novocure Inc. Read more
InHealth names Fleischman interim director
Venture capitalist and entrepreneur Charles Fleischman was named interim executive director and COO of the Institute for Health Technology Studies. Read more
Smith & Nephew chairman knighted
Smith & Nephew chairman John Buchanan was knighted by the Queen of England in recognition of his services to the med-tech industry. Buchanan joined the SNN board in 2005. Read more
Solano named chief operating officer at Veniti
Med-tech maker Veniti named former AngioDynamics executive Scott Solano as its COO. Solano replaced Joseph Tartaglia, who recently left the company. Read more
Lantheus Medical’s CFO to retire
North Billerica, Mass.-based Lantheus Medical’s CFO Robert Gaffey retired, effective earlier this week. Jeffery Young replaced Gaffey. Read more
Globus Medical appoints new CFO
Spinal implant maker Globus Medical Inc appointed financial industry veteran Richard Baron as its new senior vice president and CFO. Read more
Burrill & Company VC Group names managing director
David Wetherall joined Burrill & Company venture capital group as a managing director. The firm also appointed Dr. Douglas Lind as managing director and Joshua Zelig as director. Read more
Accera appoints Kunze CEO
Broomfield, Colo.-based Accera Inc. named industry veteran Holger Kunze as CEO and a member of the company’s board of directors. Sven Thormahlen was also appointed to Accera’s board. Read more
SNN adds board member
Jay Piramal was added as a new non-executive director to med-tech titan Smith & Nephew’s board of directors. The board now has of 11 members. Read more
Blair resigns from NewCardio board
Robert Blair resigned from NewCardio’s board of directors and governance committee. With the resignation, the cardiac device maker’s board stands at 5. Read more
IntelliCell BioSciences adds 2 to medical advisory board
Orthopedic surgeons and sports medicine docs Dr. James Andrews and Dr. Joshua Hackel joined the medical advisory board of IntelliCell BioSciences Inc. Read more
Imaging3 names Carrega as director
Imaging device maker Imaging3 Inc. named Raul Carrega as chairman of the board of directors and sole member of the audit committee. Concurrently, Xavier Aquilera voluntarily resigned as a member of the audit committee. Read more
Rochester Medical director to retire
Stewartville, Minn.-based Rochester Medical Corp.’s Roger Schnobrich will retire from the company’s board of directors, effective January 26, 2012. Read more
FlouraPharma Medical adds VC to board
FlouraPharma Medical appointed venture capitalist Lawrence Atinsky to its board of directors. Atinsky is a partner at Ascent Biomedical Ventures. Read more
